Immunogenicity and safety of the 13-valent Pneumococcal Conjugate vaccine in 23- valent pneumococcal polysaccharide vaccine-naive and pre-immunized patients under treatment with chronic haemodialysis: a longitudinal quasi-experimental phase IV study S.J. Vandecasteele, D. De Bacquer, R. Caluwe, S. Ombelet, B. Van Vlem Clinical Microbiology and Infection Volume 24, Issue 1, Pages 65-71 (January 2018) DOI: 10.1016/j.cmi.2017.05.016 Copyright © 2017 Terms and Conditions
Fig. 1 Study design and outcome (LOF, lost to follow up; transplant, kidney transplantation). Clinical Microbiology and Infection 2018 24, 65-71DOI: (10.1016/j.cmi.2017.05.016) Copyright © 2017 Terms and Conditions